Sponsor pipeline

Krystal Biotech, Inc. clinical trial pipeline

Get alerts when Krystal Biotech, Inc.'s trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

Active trials by phase

Early Phase 1
1
Phase 1
3
Phase 1/2
4
Phase 3
1
Not charted: 2 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Active trials

NCT IDTitleConditionStatusUpdated
Phase 3
NCT07016750 A Study Comparing KB803 and Matched Placebo in Patients With Dystrophic Epidermolysis… Dystrophic Epidermolysis Bullosa Recruiting 2026-03-12
Phase 1/2
NCT06999733 A Study Comparing KB801 Verse Placebo in Patients With Stage 2 or 3 Neurotrophic Keratitis Neurotrophic Keratitis Recruiting 2026-02-27
NCT06228326 A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting… Lung Cancer, Non-small Cell Recruiting 2025-10-24
NCT05970497 A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors Cancer Recruiting 2025-05-18
NCT06724900 A Study Assessing KB304 for the Treatment of Wrinkles in Women Wrinkles in Decolletage Active, Not Recruiting 2025-05-13
Phase 1
NCT05504837 A Study Assessing KB407 for the Treatment of Cystic Fibrosis Cystic Fibrosis Recruiting 2026-05-07
NCT06049082 A Study of KB408 for the Treatment of Alpha-1 Antitrypsin Deficiency Alpha 1-Antitrypsin Deficiency Recruiting 2025-07-22
NCT04540900 A Phase I Study of KB301, a Replication-Incompetent, Non-Integrating Vector Expressing… Skin Roughness Active, Not Recruiting 2025-05-13
Early Phase 1
NCT07717346 A Study to Investigate Safety and Efficacy of KB111 for the Treatment of Hailey-Hailey… Hailey Hailey Disease Recruiting 2026-07-21
Not specified
NCT06563414 A Natural History Study of Corneal Abrasions in Patients With Dystrophic Epidermolysis… Epidermolysis Bullosa Dystrophica Recruiting 2025-07-02
NCT04917887 Long-Term Follow-up Protocol Dystrophic Epidermolysis Bullosa Recruiting 2021-06-08

Disease areas by active trials

Cystic Fibrosis (1) · Lung Cancer (1) · Melanoma (1) · Non-Small Cell Lung Cancer (NSCLC) (1)

Get alerts when Krystal Biotech, Inc.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free